Antigoni Varahidis Guevara, FNP-BC
NPI 1043596059ActiveIndividual· Nurse Practitioner, Family· Spring, TX
Nurse Practitioner, Family (FNP-BC) in Spring, Texas, licensed in TX, with an NPI issued in October 2011. Kyowa Kirin, Inc. was the largest of 4 companies reporting payments in 2025, $580.01 in all, mostly food and beverage.
Overview
| NPI | 1043596059 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | FNP-BC |
| Sole proprietor | No |
| NPI issued | Oct 24, 2011 |
| Last updated in NPPES | Sep 10, 2012 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Nurse Practitioner, Family Primary | 363LF0000X | 690488 | TX |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Not in the public enrollment file of Oct 1, 2026 |
|---|
Industry payments (Open Payments)
- 2025$580.01 · 5 payments from 4 companies
- 2024$1,027 · 9 payments from 5 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Kyowa Kirin, Inc. | $250.04 | 2 |
| Gilead Sciences, Inc. | $116.15 | 1 |
| Axsome Therapeutics, Inc. | $112.12 | 1 |
| Astrazeneca Pharmaceuticals LP | $101.70 | 1 |
What the 2025 payments were for
- Food and Beverage$580.01 · 5 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other family nurse practitioners in Spring
- 1003648312
- 1023318904
- 1053907451
- 1093415747
- 1114405016
- 1144798414
- 1205244753
- 1235794777
- 1346961307
- 1386154995
- 1417426842
- 1417526153
All 198 family nurse practitioners in Spring · All family nurse practitioners in Texas